Fatty liver disease (MASLD/MASH): open trials in Greece

• 2024-512895-36-00

  A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH)

  Trial Treatment · Phase 3 · Akero Therapeutics Inc.

  Hippokration Hospital, Athens · Ippokratio General Hospital of Thessaloniki, Thessaloniki

  Registry updated 2026-10-23

• 2026-525755-82-00

  A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)

  Trial Treatment · Phase 3 · Glaxosmithkline Research & Development Limited

  Hippokration Hospital, Athens · Evangelismos S A, Athens · Laiko General Hospital of Athens, Athens · University General Hospital of Heraklion, Heraklion · Hippokration Hospital, Thessaloniki · University General Hospital of Thessaloniki - AHEPA, Thessaloniki

  Registry updated 2026-10-19

• 2026-525757-37-00

  A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)

  Trial Treatment · Phase 3 · Glaxosmithkline Research & Development Limited

  Laiko General Hospital of Athens, Athens · Hippokration Hospital, Athens · Evangelismos S A, Athens · University General Hospital of Heraklion, Heraklion · University General Hospital of Thessaloniki - AHEPA, Thessaloniki · Hippokration Hospital, Thessaloniki

  Registry updated 2026-10-19

• NCT07221188

  A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

  Trial Treatment · Phase 3 · GlaxoSmithKline

  Hippokration Hospital, Athens · Evangelismos S A, Athens · Laiko General Hospital of Athens, Athens · University General Hospital of Heraklion, Heraklion · Hippokration Hospital, Thessaloniki · University General Hospital of Thessaloniki - AHEPA, Thessaloniki

  Registry updated 2026-09-17

• NCT05651724

  Global Research Initiative for Patients Screening on MASH

  Research · Julius Clinical

  Harokopio University of Athens, Athens

  Registry updated 2024-08-01

• NCT04442334

  The European NAFLD Registry

  Research · Newcastle University

  Laiko General Hospital of Athens, Athens

  Registry updated 2023-01-06

All Fatty liver disease (MASLD/MASH) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error